Hinge Health (HNGE) Q3 2026 earnings review
Hinge Health raises its 2026 outlook, while stock taxes drain cash
Hinge Health's digital physical therapy platform is signing employers at a record pace while automated care delivery lifts profit margins. Third-quarter revenue rose 52% to $235 million, and 12-month calculated billings — invoiced amounts that lead future sales — climbed 54%. Operating margin excluding one-offs reached 33%, beating the company's plan and prompting chief executive Daniel Perez to raise the full-year outlook again.
| Revenue from businesses owned a year ago | +51% by our math; total revenue +52% to $235M |
|---|---|
| 12-month calculated billings | $960.3M +54% from a year ago |
| Operating margin, excluding one-offs | 33% 20% a year ago; 28% outlook |
| Full-year revenue outlook | Raised $22M middle of the range: $880M (+50%) |
⚖️ Verdict: 🟢 Bullish
The story got better because billings growth sped up to 54% and operating margin expanded despite closing the Cylinder Health acquisition. Furthermore, employer clients for the new migraine program nearly doubled in three months. One caution: the company spent $97 million in cash to pay taxes on insiders' and employees' vested stock awards, which drained cash and let the share count rise despite buybacks.
The question now is whether fast employer sign-ups for migraine and digestive care will bring in paying members or merely bundle extra services into existing subscriptions. If they bring new members, revenue growth will stay near 50%; if they only bundle, growth will follow the fourth-quarter plan toward 40%. Next quarter's 2027 outlook and annual member enrollment rate will settle it.
🐂 Bull Case
Billings and New Clients Show Record Selling Season
Hinge Health sells digital physical therapy and care programs to employers, signing most of its annual contracts in the second half of the year. Chief executive Daniel Perez said the company's technology platform is "resulting in a record sales season." The third-quarter numbers back up his claim across every forward indicator, while small-business channel additions due in early 2027 were not updated in the release.
- 12-month calculated billings (invoiced amounts that lead revenue): $960.3 million, up 54% from a year ago
- Deferred revenue (cash billed for service not yet delivered): $459.2 million, up 53.2% from a year ago
- Active employer clients: 3,270, up 28% from a year ago after adding 341 clients this quarter
- Revenue from businesses owned a year ago: up about 51% by our math, stripping out roughly $2 million from the new Cylinder Health deal
These figures matter because Hinge Health recognizes subscription revenue evenly over 12 months, so third-quarter billings and client additions fund next year's revenue. Adding 341 clients in one quarter — compared with 201 in the same quarter last year — shows employers are buying before the fourth-quarter rush. What to watch: fourth-quarter annual member yield (the share of eligible employees who join), which will show how much existing clients drove the full-year outlook raise.
Lower Sales and Tech Costs Lifted Margin to 33%
The digital care provider uses artificial intelligence and smartphone motion tracking to automate physical therapy, aiming to care for more members without hiring matching numbers of clinicians. Earlier this year, shipments of its Enso wearable pain-relief device and a one-time tariff refund raised questions about whether gross margin (profit left after the direct cost of delivering care) would slip back toward management's 82% to 85% long-term target.
Instead, gross margin excluding one-offs rose to 88%, up 5 percentage points from a year ago and 1 point above last quarter. Operating margin excluding one-offs reached 33%, up 13 percentage points from a year ago and 5 points above management's own 28% outlook. Every major expense line shrank as a share of sales: sales and marketing fell 4 points to 33%, research and development dropped 2 points to 12%, and general overhead fell 1 point to 10%.
Absorbing the newly acquired Cylinder Health business without a margin dip proves the core platform scales with very little extra cost. What to watch: first-quarter 2027 gross margin when newly signed migraine and digestive care clients launch. A reading that stays above 85% would show new hardware and specialist care do not dilute profitability.
Migraine and Digestive Programs Add Clients Fast
Hinge Health is expanding beyond muscle and joint care into a multi-condition platform so employers can buy several health programs from one vendor. During the third quarter, the company closed its purchase of Cylinder Health, a virtual digestive care provider, for $97.4 million in cash net of cash acquired. It also paid $9.0 million in cash for a separate asset purchase.
Employers are signing up for the new programs rapidly. Perez said the client base grew "almost 30% YoY for our MSK Care Program", rose "roughly 40% for our GI Care Program since our acquisition announcement of Cylinder Health in August", and "nearly doubled for our Migraine Care Program since last quarter". Because the migraine program had 450 clients in June, nearly doubling puts it near 900 clients today.
Fast cross-selling shows employers want to consolidate digital health vendors. What to watch: the 2027 revenue outlook next quarter, which will show how much these new programs add to member enrollment.
🐻 Bear Case
Stock Taxes and Deal Costs Cut Cash by $117 Million
Management highlights its cash generation and a $300 million share buyback expansion approved in July as signs of capital discipline. In the third quarter, the company generated $112.7 million in free cash flow (operating cash flow minus equipment and software spending). Yet total cash and marketable securities dropped by $117.1 million in three months to $358.5 million.
Two large cash outflows explain the drop. Alongside the $106.4 million spent on acquisitions, Hinge Health paid $96.6 million in cash to cover tax withholdings on employees' and founders' vested stock awards — eating up 86% of the quarter's free cash flow. Meanwhile, management spent only $25.9 million buying back shares. Because stock awards outpaced buybacks, diluted shares excluding one-offs rose to 86.5 million, up from 83.4 million last quarter.
Using nearly all of a quarter's free cash flow to settle insider and employee stock taxes while share count rises works against shareholders. What to watch: fourth-quarter cash used for stock tax withholdings and total diluted shares against the 85 million to 87 million year-end target. Another large tax settlement would keep share count rising despite the buyback program.
New Programs And President Exit Leave 2027 Questions
Hinge Health relies on its commercial team to turn employer contracts into enrolled members, and it is counting on new conditions to keep growth high. On November 2, the company announced that President Jim Pursley will step down on January 1, 2027, and join the board. Perez said, "He's been instrumental in our scaling to over 3,200 clients." Aaryn Pure will take over to "lead the commercial organization as Chief Commercial Officer".
The commercial handoff happens just as the company prepares for the "anticipated launch of our integrated Gastrointestinal Care Program in 2027". While client counts for migraine and digestive care are rising fast, Hinge Health charges per enrolled member, and by our math the fourth-quarter outlook has revenue growth from businesses owned a year ago slowing from 51% to about 43%.
A commercial leadership change during the main launch year for two new product lines adds execution risk. What to watch: the initial 2027 revenue outlook next quarter. A forecast below 35% growth would indicate that new programs are not yet offsetting the natural slowdown in the core joint-care business.
Risks this quarter didn't answer
Several standing concerns around acquisitions, competition and pricing mechanics received no new data in the third-quarter earnings release.
- Cylinder Health standalone finances: the release did not disclose Cylinder's exact revenue contribution, operating losses, client concentration or plans for its GutCheck test; the quarterly filing's acquisition footnote will show the purchase price allocation and revenue.
- Competitive win rates: management gave no head-to-head win rate figures to counter claims from private rivals; the earnings call Q&A is the next place this may surface.
- Annual member yield: Hinge Health only reports the percentage of eligible employees who join its programs at year-end, so the fourth-quarter release will show whether yield topped the 4.45% target.
💲 Other KPIs
Free cash flow rose 38.6% from a year ago to $112.7 million, up from $99.6 million in the second quarter and $41.6 million in the first. That equals 48% of revenue, up from 47% last quarter but down from 53% a year ago because the company collected less cash upfront from receivables.
Uncollected customer bills rose 71.2% from a year ago and 18.4% from last quarter, outpacing the 52.4% rise in revenue. Accounts receivable — money clients owe for billed services — grew as third-quarter billings rose and Cylinder Health joined the balance sheet, creating an $18.4 million drag on operating cash flow.
Deferred commissions — sales commissions paid to reps that the US company spreads over the life of a client contract — rose 60.4% from a year ago and 48.7% since December. New commission payments took $25.2 million in cash this quarter against $10.7 million a year ago, confirming heavy third-quarter contract signings.
🔮 Guidance
New. The plan calls for 46% revenue growth at the middle of the range, down from 52.4% in the third quarter. By our math, that is $11.1 million above what the prior full-year plan left for the fourth quarter, and implies about 43% growth from businesses owned a year ago. Hinge Health has beaten its quarterly revenue plan five times in a row by an average of 7.0%; if the pattern holds, fourth-quarter revenue would reach $267 million.
New. The forecast points to 71% profit growth and a 33% operating margin excluding one-offs at the middle of the range, matching the third quarter's 33% margin. By our math, this sits $11.7 million above what the prior full-year outlook implied for the fourth quarter. Over the last five quarters, profit excluding one-offs beat the middle of the plan by an average of 39.7%; if the pattern holds, fourth-quarter profit would reach $115 million.
Raised. Management lifted the middle of the full-year revenue plan by $22 million to $880 million, or 50% growth from a year ago. Half of the increase comes from the $11 million third-quarter beat, and half comes from a higher fourth-quarter outlook. It is the third raise this year, and each step has been smaller as the year nears its close: +$64M, +$57M, +$22M.
Raised. The healthcare company increased its full-year profit outlook by $27 million at the middle of the range, lifting the full-year operating margin target by 2 percentage points to 30%. That is the third raise this year following increases of $56.5 million, $30.0 million and now $27.0 million, proving the business can absorb Cylinder Health's operating losses while still expanding margins.
❓ Key Questions
How much revenue did Cylinder Health add in Q3?
Hinge Health closed the Cylinder Health purchase in the third quarter and paid $97.4 million net of cash, plus $9.0 million for an asset purchase. Disclosing Cylinder's standalone revenue and operating loss is necessary to measure underlying growth and margin expansion.
Are more cash tax settlements coming for insider stock awards?
The company spent $96.6 million in cash on tax withholdings for vested restricted stock units in the third quarter — more than the $77.5 million previously flagged for founders — while spending only $25.9 million on buybacks. Investors need to know if further cash settlements remain.
When do new migraine and digestive clients generate revenue?
Migraine client counts nearly doubled from last quarter and digestive care clients rose 40% since August, but Hinge Health charges per enrolled member rather than per employer client. Management has not said how much revenue these signings will add in 2027.
Why is the commercial leadership changing before the 2027 launches?
President Jim Pursley is stepping down on January 1, 2027, handing commercial leadership to Chief Commercial Officer Aaryn Pure just as the integrated digestive program launches. Clarifying whether sales structure or quota targets are changing will help assess execution risk.